EndoChoice has launched its initial public offering. Here are five things to know about the GI/endoscopy company's IPO.
1. The IPO represents 6.25 million shares of common stock, 25.6 percent of the company's outstanding common stock following its conversion into a Delaware corporation in connection with the offering.
2. The IPO is expected to be $15 to $17 per share.
3. J.P. Morgan and BofA Merrill Lynch are the joint lead book-running managers for the offering. William Blair and Stifel are co-managers of the offering.
4. The offering's underwriters will have a 30-day option to purchase up to an additional 937,500 shares of the company's common stock.
5. EndoChoice applied to list its common stock under the symbol "GI" on the New York Stock exchange.